LORIA, Paola
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.590
EU - Europa 6.660
AS - Asia 1.719
SA - Sud America 21
AF - Africa 13
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 8
Totale 24.022
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.568
GB - Regno Unito 2.591
IT - Italia 982
SE - Svezia 936
DE - Germania 752
CN - Cina 700
UA - Ucraina 538
TR - Turchia 453
HK - Hong Kong 387
FI - Finlandia 287
BG - Bulgaria 204
FR - Francia 175
IN - India 47
RU - Federazione Russa 47
BE - Belgio 28
NL - Olanda 28
MY - Malesia 21
SG - Singapore 20
CA - Canada 17
ES - Italia 16
JP - Giappone 15
LT - Lituania 15
IR - Iran 14
IE - Irlanda 13
BD - Bangladesh 11
KR - Corea 10
RO - Romania 10
TW - Taiwan 10
AU - Australia 8
CL - Cile 8
CH - Svizzera 7
EU - Europa 7
SI - Slovenia 6
AT - Austria 5
ET - Etiopia 5
IQ - Iraq 5
MX - Messico 5
AR - Argentina 4
BR - Brasile 4
PH - Filippine 4
UG - Uganda 4
VN - Vietnam 4
CY - Cipro 3
GE - Georgia 3
GR - Grecia 3
HU - Ungheria 3
NZ - Nuova Zelanda 3
CZ - Repubblica Ceca 2
EC - Ecuador 2
EG - Egitto 2
HR - Croazia 2
KW - Kuwait 2
PK - Pakistan 2
PL - Polonia 2
RS - Serbia 2
TH - Thailandia 2
TJ - Tagikistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BF - Burkina Faso 1
BO - Bolivia 1
BY - Bielorussia 1
ID - Indonesia 1
JO - Giordania 1
KZ - Kazakistan 1
LV - Lettonia 1
MD - Moldavia 1
MO - Macao, regione amministrativa speciale della Cina 1
MU - Mauritius 1
NO - Norvegia 1
PE - Perù 1
PT - Portogallo 1
VE - Venezuela 1
Totale 24.022
Salva come PNG Salva come JPEG
Città #
Fairfield 2.189
Southend 2.017
Woodbridge 1.601
Houston 1.276
Jacksonville 1.218
Chandler 1.197
Ashburn 1.135
Seattle 832
Dearborn 796
Ann Arbor 776
Wilmington 761
Cambridge 720
Nyköping 546
Hong Kong 383
Modena 303
Beijing 296
Izmir 283
San Diego 235
Princeton 220
Sofia 204
Eugene 201
Des Moines 166
New York 141
Grafing 101
Helsinki 90
Falls Church 86
London 82
Shanghai 60
Bremen 58
Milan 43
Boardman 40
Redwood City 39
Rome 39
Norwalk 35
Kunming 34
San Mateo 33
Fremont 31
Hefei 31
Brussels 25
Kilburn 23
Nanjing 19
Verona 19
Hounslow 18
Bari 17
Bologna 17
Jinan 17
Dongguan 16
Chiswick 14
Guangzhou 14
Nanchang 14
Dublin 11
Parma 11
Indiana 10
Phoenix 10
Auburn Hills 9
Augusta 9
Florence 9
Shenyang 9
Singapore 9
Taipei 9
Formia 8
Genova 8
Islington 8
Leawood 8
Madrid 8
Mountain View 8
Saint Petersburg 8
San Francisco 8
Toronto 8
Amsterdam 7
Baotou 7
Chicago 7
Fuzhou 7
Turin 7
Washington 7
Chengdu 6
Chongqing 6
Dhaka 6
Istanbul 6
Los Angeles 6
Monmouth Junction 6
Monza 6
Napoli 6
Prescot 6
Rio Saliceto 6
Santeramo in Colle 6
Sydney 6
Baghdad 5
Bangalore 5
Frankfurt am Main 5
Hebei 5
Livorno 5
Nishinotoindori 5
Wandsworth 5
Avigliano 4
Busto Arsizio 4
Castelnuovo Rangone 4
Clearwater 4
Hanover 4
Kampala 4
Totale 18.852
Salva come PNG Salva come JPEG
Nome #
Neoangiogenesis-related genes are hallmarks of fast-growing hepatocellular carcinomas and worst survival. Results from a prospective study 295
Herpesvirus DNA is frequently detected in liver tissue from hepatitis C patients 260
ABCB4 and ABCB11 mutations in intrahepatic cholestasis of pregnancy in an Italian population 217
Suppression of bile acid synthesis, but not of hepatic cholesterol 7alpha-hydroxylase expression, by obstructive cholestasis in humans 213
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 213
Effects of bile duct ligation and cholic acid treatment on fatty liver in two rat models of non-alcoholic fatty liver disease 203
Age-associated alterations in cholesterol homeostasis: evidence from a cross-sectional study in a Northern Italy population. 199
Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes 199
Nonalcoholic Fatty Liver Disease in HIV-Infected Patients Referred to a Metabolic Clinic: Prevalence, Characteristics, and Predictors 194
Increased appearance rate of 27-hydroxycholesterol in vivo in hypercholesterolemia: A possible compensatory mechanism. 188
Comparative cytotoxic and cytoprotective effects of taurohyodeoxycholic acid (THDCA) and tauroursodeoxycholic acid (TUDCA) in HepG2 cell line. 187
Gender, fatty liver and GGT 186
Prophylaxis of venous thromboembolism in elderly patients with multimorbidity 185
Nonalcoholic fatty liver disease and aging: epidemiology to management 185
Is nonalcoholic steatohepatitis associated with a high-though-normal thyroid stimulating hormone level and lower cholesterol levels? 177
Magnetic resonance for quantitative assessment of liver steatosis: a new potential tool to monitor antiretroviral-drug-related toxicities. 176
Hepatocellular carcinoma in a patient treated with efalizumab for psoriasis. 175
Short-term multidisciplinary non-pharmacological intervention is effective in reducing liver fat content assessed non-invasively in patients with nonalcoholic fatty liver disease (NAFLD) 175
Risk factors for hospital readmission of elderly patients 172
Human Immunodeficiency Virus Is the Major Determinant of Steatosis and Hepatitis C Virus of Insulin Resistance in Virus-associated Fatty Liver Disease. 172
Il pool degli acidi biliari quale regolatore del metabolismo epatico del colesterolo: sintesi degli acidi biliari. 171
Risk for cardiovascular events in an Italian population of patients with type 2 diabetes 170
Review article: the metabolic syndrome and non-alcoholic fatty liver disease 169
Effect of liver cirrhosis on the systemic availability of naltrexone in humans 168
Hepatitis C virus-infected patients are 'spared' from the metabolic syndrome but not from insulin resistance. A comparative study of nonalcoholic fatty liver disease and hepatitis C virus-related steatosis 166
In Vivo Degradation of Cholesterol to Bile Acids Is Reduced in Patients Receiving Parenteral Nutrition. 166
Pathogenesis and significance of hepatitis C virus steatosis: An update on survival strategy of a successful pathogen 166
Liver and kidney foreign bodies granulomatosis in a patient with malocclusion, bruxism, and worn dental prostheses 166
Decreased hepatic expression of PPAR-gamma coactivator-1 in cholesterol cholelithiasis. 166
Review article: diabetes, genetics and ethnicity 164
Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology. 161
Treatment of atherogenic liver based on the pathogenesis of nonalcoholic Fatty liver disease: a novel approach to reduce cardiovascular risk? 157
Endocrine and liver interaction: the role of endocrine pathways in NASH 157
Incidence of gallstone disease in Italy: Results from a multicenter, population-based Italian study (the MICOL project) 156
Is liver fat detrimental to vessels?: intersections in the pathogenesis of NAFLD and atherosclerosis 155
Classical and innovative insulin sensitizing drugs for the prevention and treatment of NAFLD 154
The hepatitis C virus-associated dysmetabolic syndrome. 154
Cholesterol absorption in cirrhosis: the role of total and individual bile acid pool size 153
Patogenesi della colelitiasi. I. Colelitiasi colesterinica. 151
Natural history of gallstone disease: Expectant management or active treatment? Results from a population-based cohort study. 151
Chronic hepatitis C virus infection and atherosclerosis: Clinical impact and mechanisms. 151
From NAFLD in clinical practice to answers from guidelines. 150
Do diabetes and obesity promote hepatic fibrosis in familial heterozygous hypobetalipoproteinemia? 150
Advances in the comprehension of the pathophysiology of bile secretion 149
Bile acid feeding and hepatic sterol metabolism: effect of deoxycholic acid. 149
Statins and HCV: a complex issue 147
Nonalcoholic fatty liver disease in HIV-infected persons: epidemiology and the role of nucleoside reverse transcriptase inhibitors. 147
Effects of acute changes of bile acid pool composition on biliary lipid secretion 146
Intestinal solubilization, absorption, pharmacokinetics and bioavailability of chenodeoxycholic acid. 145
Effect of the selective expansion of cholic acid pool on bile lipid composition: possible mechanism of bile acid induced biliary cholesterol desaturation. 144
NAFLD and cardiovascular risk: direct evidence for the tale of two ages. 143
Chicken or egg turned into head or belly 142
Non-alcoholic fatty liver disease (NAFLD) and cardiovascular disease: An open question 142
Effect of taurohyodeoxycholic acid on biliary lipid secretion in humans 141
Progetto MICOL - Multicentrica Italiana Colelitiasi 141
Review article: hepatic steatosis and insulin resistance 140
Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease. A decalogue from the Italian Association for the Study of the Liver (AISF) Expert Committee. 140
Determinants of bile secretion: effect of bile salt structure on bile flow and biliary cation secretion 138
Growth hormone plasma levels in nonalcoholic fatty liver disease 137
Nonalcoholic fatty liver disease activity score and Brunt's pathologic criteria for the diagnosis of nonalcoholic steatohepatitis: what do they mean and do they agree? 137
Ultrasonographic fatty liver indicator, a novel score which rules out NASH and is correlated with metabolic parameters in NAFLD. 137
Of liver, whisky and plants: A requiem for colchicine in alcoholic cirrhosis? 137
Is cholangiocarcinoma another complication of insulin resistance: A report of three cases 136
Cardiovascular and Systemic Risk in Nonalcoholic Fatty Liver Disease -Atherosclerosis As a Major Player in the Natural Course of NAFLD. 136
The effect of chenodeoxycholic acid (CDCA) on cholesterol absorption. 135
Genetic determinants of susceptibility and severity in nonalcoholic fatty liver disease. 135
Apolipoprotein synthesis in nonalcoholic steatohepatitis 134
Nonalcoholic fatty liver disease induced by leuprorelin acetate 134
Liver and diabetes. A vicious circle 134
Relationship of serum fetuin-a levels with coronary atherosclerotic burden and NAFLD in patients undergoing elective coronary angiography. 134
Fisiologia della secrezione biliare. 132
The prediction of coronary heart disease mortality as a function of major risk factors in over 30.000 men in the italian RIFLE Pooling Project. A comparison with the MRFIT primary screenees 132
Metabolic alterations and chronic hepatitis C: treatment strategies. 132
'Endocrine NAFLD' a hormonocentric perspective of nonalcoholic fatty liver disease pathogenesis 131
Fasting insulin and uric acid levels but not indices of iron metabolism are independent predictors of non-alcoholic fatty liver disease. A case-control study 130
Clinical physiology of NAFLD: A critical overview of pathogenesis and treatment 130
Hepatic cholesterol and bile acid metabolism in subjects with gallstones: comparative effects of short erm feeding of chenodeoxycholic and ursodeoxycholic acid 129
Insulin resistance in nonalcoholic steatohepatitis: necessary but not sufficient - death of a dogma from analysis of therapeutic studies? 129
NAFLD AND TYPE 2 DIABETES: A GENETIC OR METABOLIC ISSUE? 129
MR techniques in the qualitative analysis of liver steatosis: the potential in the differentiation between steatohepatatis and steatosis 128
Dysmetabolic changes associated with HCV: a distinct syndrome? 128
Influence of age and sex on serum concentrations of total dimeric activin A 127
Anatomia e fisiologia delle vie biliari 127
Effect of ursocholic acid on bile lipid secretion and composition 126
Presentation of the RIFLE Project : Risk factors and life expectancy. 126
Hepatitis C and diabetes: the inevitable coincidence? 126
Effect of diabetic autonomic neuropathy on gallbladder kinetics in insulin dependent diabetic patients 126
MOLECULAR REGULATION OF STEROL METABOLISM BY BILE ACIDS IN CULTURED HUMAN HEPATOCYTES 126
Non-organ-specific autoantibodies in nonalcoholic fatty liver disease: Prevalence and correlates 126
Nonsynonymous mutations within APOB in human familial hypobetalipoproteinemia: evidence for feedback inhibition of lipogenesis and postendoplasmic reticulum degradation of apolipoprotein B. 126
'True' antimitochondrial antibody-negative primary biliary cirrhosis, low sensitivity of the routine assays, or both? 125
ESTIMATION OF CARDIOVASCULAR RISK IN TYPE 2 DIABETES 125
Non-alcoholic Fatty Liver Disease: a HR-MAS analysis 124
RISK FOR CARDIOVASCULAR EVENTS IN AN ITALIAN POPULATION OF PATIENTS WITH TYPE 2 DIABETES 124
Nuclear receptors as potential molecular targets in cholesterol accumulation conditions: Insights from evidence on hepatic cholesterol degradation and gallstone disease in humans 124
The neck-liver axis. Madelung disease as further evidence for an impact of body fat distribution on hepatic histology 124
Steatosis and hepatitis C virus: mechanisms and significance for hepatic and extrahepatic disease 123
Diet and gallstones in Italy: the cross-sectional MICOL results. 123
Role of body mass index in the prediction of all cause mortality in over 62,000 men and women. The Italian RIFLE Pooling Project. Risk Factor and Life Expectancy. 123
Bile acid structure and regulation of biliary protein secretion and composition in man 121
Totale 15.225
Salva come PNG Salva come JPEG
Categoria #
all - tutte 93.400
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 93.400
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.644 0 0 0 0 0 0 0 0 0 0 763 881
2019/20205.450 399 404 194 358 569 865 941 502 474 172 332 240
2020/20213.733 363 139 324 320 391 294 369 545 133 452 257 146
2021/20223.583 51 502 394 313 87 156 261 204 392 213 607 403
2022/20233.279 363 354 205 326 401 583 72 310 385 29 142 109
2023/20241.757 84 119 114 136 457 221 216 286 56 42 26 0
Totale 24.171